Insights on the knowledge and practical implementation of the professional ethics of privacy and confidentiality among practising pharmacists across 17 countries are shared today in a new report launched by FIP’s Community Pharmacy Section (CPS). Although with the available data a number of indicators of good practice were found, some of the findings of the survey are concerning, the authors say. For example, the report indicates gaps in current training programmes (both pre- and post-graduation) and, in some pharmacies, an infrastructure that is not conducive to preserving confidentiality. “Our profession is undergoing a transformation towards more clinical roles in patient care, providing services such as medication therapy management (often requiring collaboration with other healthcare professionals), immunisation and health screening. Lack of privacy and confidentiality in certain geographical areas are crucial obstacles that could inhibit service utilisation,” the authors of the report “Ethics and the pharmacist: Privacy and confidentiality” say. The work was supported by FIP’s Board of Pharmaceutical Practice (BPP) and in a communication to FIP members, both the BPP chair and the CPS president said that a collective effort is required to improve the current situation observed in the study so that community pharmacy is well-equipped to advance the profession.